State Street’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.4K | Hold |
16,004
| – | – | ﹤0.01% | 4190 |
|
|
2025
Q1 | $28.3K | Hold |
16,004
| – | – | ﹤0.01% | 4166 |
|
|
2024
Q4 | $36.8K | Buy |
16,004
+5,600
| +54% | +$12.9K | ﹤0.01% | 4155 |
|
|
2024
Q3 | $36.8K | Hold |
10,404
| – | – | ﹤0.01% | 4144 |
|
|
2024
Q2 | $28.8K | Buy |
+10,404
| New | +$28.8K | ﹤0.01% | 4235 |
|
|
2022
Q4 | – | Sell |
-5,104
| Closed | -$21K | – | 4904 |
|
|
2022
Q3 | $21K | Hold |
5,104
| – | – | ﹤0.01% | 4827 |
|
|
2022
Q2 | $27K | Buy |
5,104
+1,544
| +43% | +$8.17K | ﹤0.01% | 4835 |
|
|
2022
Q1 | $36K | Hold |
3,560
| – | – | ﹤0.01% | 4845 |
|
|
2021
Q4 | $40K | Hold |
3,560
| – | – | ﹤0.01% | 4732 |
|
|
2021
Q3 | $73K | Hold |
3,560
| – | – | ﹤0.01% | 4606 |
|
|
2021
Q2 | $89K | Buy |
+3,560
| New | +$89K | ﹤0.01% | 4384 |
|
|
2018
Q2 | – | Sell |
-1,893
| Closed | -$309K | – | 3807 |
|
|
2018
Q1 | $309K | Buy |
1,893
+270
| +17% | +$44.1K | ﹤0.01% | 3499 |
|
|
2017
Q4 | $342K | Buy |
1,623
+764
| +89% | +$161K | ﹤0.01% | 3504 |
|
|
2017
Q3 | $229K | Buy |
+859
| New | +$229K | ﹤0.01% | 3586 |
|